Evidence map›Paper›PMID 40385390›Full record

ArticlemedRxiv : the preprint server for health sciences2025

What Dose of Methamphetamine Do Regular Consumers Use Daily? Estimating Milligrams of Oral Amphetamine Equivalent.

Joseph R Friedman, Adam J Koncsol, Caitlin A Molina, Ruby Romero, Jasmine Feng, Michelle Poimboeuf, Morgan E Godvin, Siddarth Puri, Carla Marienfeld, Chelsea L Shover

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Joseph R FriedmanDepartment of Psychiatry, University of California, San Diego.
Adam J KoncsolDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.
Caitlin A MolinaDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.
Ruby RomeroDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.
Jasmine FengDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.
Michelle PoimboeufDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.
Morgan E GodvinDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.
Siddarth PuriMedical Director, County of San Luis Obispo, California.
Carla MarienfeldDepartment of Psychiatry, University of California, San Diego.
Chelsea L ShoverDepartment of General Internal Medicine and Health Services Research, University of California, Los Angeles.

Funding

NRSA Training CoreTL1TR001883 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, Nina Thawata Harawa · 2016 to 2026
$8.6M
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
Predicting fatal and non-fatal overdose in Los Angeles County with Rapid Overdose Surveillance Dashboard to target street-based addiction treatment and harm reduction servicesR01DA057630 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI David Goodman, Chelsea Leigh Shover · 2022 to 2026
$2.9M
Psychiatry Research Residency Training TrackR25MH101072 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NEAL R SWERDLOW · 2013 to 2026
$2.8M
Adoption and scale-up of long-acting medications for opioid use disorder by U.S. clinicians.K01DA050771 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHOVER, CHELSEA LEIGH · 2021 to 2025
$893k
NCATS NIH HHS TL1 TR001883NIDA NIH HHS K01 DA050771NIDA NIH HHS R01 DA049644NIDA NIH HHS R01 DA057630NIMH NIH HHS R25 MH101072
6 · The paper itself

Abstract

Introduction: The purity, accessibility, and affordability of illicit methamphetamine has increased in recent decades, which has been linked to rising rates of methamphetamine-involved overdoses, psychosis, cardiovascular events, and other health consequences. Nevertheless, information about the quantity of methamphetamine used by regular consumers has been limited, despite the potential clinical utility of exposure quantification. Methods: From August 2024-April 2025, self-reported daily methamphetamine consumption was assessed among n=68 individuals. Methamphetamine samples (n=112) were analyzed for purity using liquid chromatography-mass spectrometry. Percent bioavailability by route of administration and stimulant equivalency were obtained from literature. A simulation model leveraging bootstrapping was used to estimate MOAE. Results: The average reported daily methamphetamine consumption was 0.96g (median 0.36g; range 0.1g-4.0g). Average purity was 71.6% (median 75.5%; range 0.1%-95.0%). Given estimated average bioavailability of 52.0% when smoked, 79.3% when insufflated, 67.2% orally or inserted rectally, and a 2:1 amphetamine-methamphetamine equivalency, the average consumer used 1,549.0 MOAE daily (median 516.6; range 1.3-10,112.0). Discussion: We estimate that consumers of methamphetamine in Los Angeles use an average daily stimulant dose (>1,500 MOAE) that is 25-fold higher than the maximum typical recommended clinical dose of mixed amphetamine salts (60mg). This may help explain the limited efficacy of prescription stimulant treatment for methamphetamine use disorder, which typically employs considerably lower quantities. Given this high dose, these findings shed light on the rising incidence of methamphetamine-related sequalae, such as psychosis, cardiovascular complications, and sudden death. Although exposure quantification is commonplace for alcohol and tobacco use disorders, uncertainties in illicit drug markets has complicated this practice for most illicit drugs. This study supports leveraging emerging information from drug checking programs so that clinicians can approximate exposure quantification.

Identifiers

PMID40385390
PMCPMC12083619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.